SCHEMBL26795337

SCHEMBL26795337

CC(F)(CO)c1ccc(-c2cc3ccn(CC4CCCCC4)c(=O)c3cc2F)nc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 1/20 0.35
▸ PDE4B Q07343 1/20 0.35
▸ PDE4C Q08493 1/20 0.35
▸ PDE4D Q08499 1/20 0.35
▸ MAP3K5 Q99683 1/20 0.35
▸ KIT P10721 1/20 0.34
▸ FLT3 P36888 1/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ MTOR P42345 1/20 0.34
▸ GSK3A P49840 1/20 0.34
▸ GRM4 Q14833 1/20 0.34
▸ PDE1C Q14123 5/20 0.33
▸ PDE1A P54750 4/20 0.33
▸ PDE1B Q01064 4/20 0.33
▸ RORA P35398 1/20 0.33
▸ RORC P51449 1/20 0.33
▸ RORB Q92753 1/20 0.33
▸ TIPARP Q7Z3E1 2/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26795404 0.87 KDM1A (0.34) PDE4APDE4BPDE4CPDE4DMAP3K5
SCHEMBL26795358 0.82 PDE1C (0.38) PDE4APDE4BPDE4CPDE4DKIT
SCHEMBL26795202 0.78 PDE1C (0.42) PDE4APDE4BPDE4CPDE4DKIT
SCHEMBL26804054 0.76 PDE1C (0.36) PDE4APDE4BPDE4CPDE4DMAP3K5
SCHEMBL26800602 0.75 PDE4A (0.34) PDE4APDE4BPDE4CPDE4DKIT
SCHEMBL26800619 0.74 PSMB5 (0.38) FLT3GRM4PDE1CPDE1APDE1B
SCHEMBL26795283 0.72 GRM4 (0.34) PDE4APDE4BPDE4CPDE4DKIT
SCHEMBL25902177 0.72 TIPARP (0.43) KITFLT3PIK3CAGRM4TIPARP
SCHEMBL26795228 0.71 GRM4 (0.38) PDE4APDE4BPDE4CPDE4DKIT
SCHEMBL26795243 0.71 PDE1C (0.39) KITFLT3PIK3CAMTORGSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365529-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. 2023-11-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365529-A1 PARP7 INHIBITORS PARP1, PARP11, PARP2 PDE4A 2530/4885PDE4B 1819/4885PDE4C 3164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback